KalVista Investigative Site

Boston, Massachusetts 02215

0 studies enrolling now · 2 studies all time

What they study most

Angioedema, Hereditary, Types I and II, Diabetic Macular Edema

Studies at this site

• A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II — Stopped early
• Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME) — Completed